Cargando…
Androgen receptor-binding sites are highly mutated in prostate cancer
Androgen receptor (AR) signalling is essential in nearly all prostate cancers. Any alterations to AR-mediated transcription can have a profound effect on carcinogenesis and tumor growth. While mutations of the AR protein have been extensively studied, little is known about those somatic mutations th...
Autores principales: | Morova, Tunç, McNeill, Daniel R., Lallous, Nada, Gönen, Mehmet, Dalal, Kush, Wilson, David M., Gürsoy, Attila, Keskin, Özlem, Lack, Nathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012874/ https://www.ncbi.nlm.nih.gov/pubmed/32047165 http://dx.doi.org/10.1038/s41467-020-14644-y |
Ejemplares similares
-
Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
por: Lallous, Nada, et al.
Publicado: (2013) -
Androgen Receptor-Mediated Transcription in Prostate Cancer
por: Özturan, Doğancan, et al.
Publicado: (2022) -
Deep Learning Modeling of Androgen Receptor Responses to Prostate Cancer Therapies
por: Snow, Oliver, et al.
Publicado: (2020) -
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
por: Ban, Fuqiang, et al.
Publicado: (2021) -
Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors
por: Radaeva, Mariia, et al.
Publicado: (2022)